CVS Health Corporation $CVS Shares Purchased by Vaughan David Investments LLC IL

Vaughan David Investments LLC IL grew its position in shares of CVS Health Corporation (NYSE:CVS) by 2.8% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 412,371 shares of the pharmacy operator’s stock after purchasing an additional 11,245 shares during the period. Vaughan David Investments LLC IL’s holdings in CVS Health were worth $31,089,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Avion Wealth lifted its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. increased its position in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the period. Corundum Trust Company INC purchased a new stake in shares of CVS Health in the third quarter valued at about $29,000. Harbor Asset Planning Inc. acquired a new position in CVS Health in the 2nd quarter valued at about $30,000. Finally, Front Row Advisors LLC lifted its position in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE CVS opened at $78.34 on Tuesday. CVS Health Corporation has a fifty-two week low of $51.79 and a fifty-two week high of $85.15. The stock has a market cap of $99.45 billion, a price-to-earnings ratio of 206.16, a price-to-earnings-growth ratio of 0.72 and a beta of 0.48. The business has a fifty day moving average of $78.85 and a 200-day moving average of $74.42. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter in the previous year, the company posted $1.09 EPS. The business’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date is Thursday, January 22nd. CVS Health’s payout ratio is presently 700.00%.

Analyst Upgrades and Downgrades

CVS has been the subject of several recent research reports. Barclays lifted their price objective on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Argus raised their price objective on shares of CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Robert W. Baird boosted their target price on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Mizuho raised their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Finally, Raymond James Financial increased their price objective on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.86.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.